Literature DB >> 17639273

Leukotrienes: mediators that have been typecast as villains.

N Flamand1, P Mancuso, C H C Serezani, T G Brock.   

Abstract

As befalls many mediators that act upon the human stage, leukotrienes have become identified with their most powerful roles as villains of the immune system. They are well known for their leading roles in allergic diseases, including asthma. They also have gained recognition for their dramatic role as promoters of inflammation. As new roles for these lipid messengers are sought, it is becoming apparent that the leukotrienes have been typecast as bad guys of the immune system. As examples, their more recent roles have been in atherosclerosis, pulmonary fibrosis and cancer. However, upon further evaluation, we can begin to see their versatility. Thus, leukotrienes stimulate innate immunity against pathogens. In addition, they promote the expression of mediators, receptors and other molecules that are important for immune defense. In these lesser known roles, they lead the fight against bacterial, fungal and viral infection. This review is intended to shed light on the leukotrienes, where they come from and what we really know about them.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639273     DOI: 10.1007/s00018-007-7228-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  27 in total

Review 1.  Arachidonic acid and ion channels: an update.

Authors:  H Meves
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

2.  Roles of Eicosanoids in Prostate Cancer.

Authors:  Kasem Nithipatikom; William B Campbell
Journal:  Future Lipidol       Date:  2008-08-01

Review 3.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

4.  Altered leukotriene B4 metabolism in CYP4F18-deficient mice does not impact inflammation following renal ischemia.

Authors:  Valeria Winslow; Rachel Vaivoda; Aleksandr Vasilyev; David Dombkowski; Karim Douaidy; Christopher Stark; Justin Drake; Evin Guilliams; Dharamainder Choudhary; Frederic Preffer; Ivaylo Stoilov; Peter Christmas
Journal:  Biochim Biophys Acta       Date:  2014-03-14

5.  Leukotriene B4-mediated sterile inflammation promotes susceptibility to sepsis in a mouse model of type 1 diabetes.

Authors:  Luciano Ribeiro Filgueiras; Stephanie L Brandt; Soujuan Wang; Zhuo Wang; David L Morris; Carmella Evans-Molina; Raghavendra G Mirmira; Sonia Jancar; C Henrique Serezani
Journal:  Sci Signal       Date:  2015-01-27       Impact factor: 8.192

6.  Generation of Bioactive Oxylipins from Exogenously Added Arachidonic, Eicosapentaenoic and Docosahexaenoic Acid in Primary Human Brain Microvessel Endothelial Cells.

Authors:  Harold M Aukema; Tanja Winter; Amir Ravandi; Siddhartha Dalvi; Donald W Miller; Grant M Hatch
Journal:  Lipids       Date:  2015-10-06       Impact factor: 1.880

Review 7.  Extracellular vesicles and their content in bioactive lipid mediators: more than a sack of microRNA.

Authors:  Eric Boilard
Journal:  J Lipid Res       Date:  2018-04-20       Impact factor: 5.922

8.  Hyaluronidase decreases neutrophils infiltration to the inflammatory site.

Authors:  Marcio Fronza; Cornélia Muhr; Denise Sayuri Calheiros da Silveira; Carlos Artério Sorgi; Stephen Fernandes de Paula Rodrigues; Sandra Helena Poliselli Farsky; Francisco Wanderley Garcia Paula-Silva; Irmgard Merfort; Lúcia Helena Faccioli
Journal:  Inflamm Res       Date:  2016-03-04       Impact factor: 4.575

9.  Phosphorylation of serine 271 on 5-lipoxygenase and its role in nuclear export.

Authors:  Nicolas Flamand; Ming Luo; Marc Peters-Golden; Thomas G Brock
Journal:  J Biol Chem       Date:  2008-11-01       Impact factor: 5.157

10.  Leukotriene B4 enhances the generation of proinflammatory microRNAs to promote MyD88-dependent macrophage activation.

Authors:  Zhuo Wang; Luciano Ribeiro Filgueiras; Soujuan Wang; Ana Paula Moreira Serezani; Marc Peters-Golden; Sonia Jancar; C Henrique Serezani
Journal:  J Immunol       Date:  2014-01-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.